XTL Biopharmaceuticals Ltd.
XTLB
$1.27
$0.043.25%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -46.09% | -49.72% | -53.78% | 3.01% | -39.27% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -59.15% | -40.77% | -46.36% | -- | -24.47% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -21.43% | -- | -- | -- | -12.50% |
| Total Current Assets | -46.24% | -49.46% | -53.48% | -52.85% | -38.98% |
|
|
|||||
| Total Current Assets | -46.24% | -49.46% | -53.48% | -52.85% | -38.98% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00% | 0.00% | 0.00% | -- | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -42.04% | -45.62% | -49.96% | -49.83% | -36.75% |
|
|
|||||
| Total Accounts Payable | -50.00% | 5.88% | -5.23% | -- | 0.00% |
| Total Accrued Expenses | 10.81% | -- | -- | -- | -19.21% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 10.16% | 5.88% | -5.23% | -7.31% | -19.05% |
|
|
|||||
| Total Current Liabilities | 10.16% | 5.88% | -5.23% | -7.31% | -19.05% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 10.16% | 5.88% | -15.98% | -68.98% | -85.45% |
|
|
|||||
| Common Stock & APIC | 0.00% | 0.00% | 0.00% | 2,645.48% | 0.00% |
| Retained Earnings | -1.14% | -1.44% | -1.84% | -- | -0.86% |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | -- | 0.00% |
| Total Common Equity | -44.49% | -47.28% | -51.14% | -47.28% | -25.01% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -44.49% | -47.28% | -51.14% | -47.28% | -25.01% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -44.49% | -47.28% | -51.14% | -47.28% | -25.01% |
|
|
|||||
